Dr. Shital Sarah Ahaley

Dr. Shital Sarah Ahaley

B.Sc. Microbiology, M.Sc. Microbiology, Ph.D. Developmental Biology

Dr. Shital Sarah Ahaley is a medical writer. She completed her Bachelor's and Master's degree in Microbiology at the University of Pune. She then completed her Ph.D. at the Indian Institute of Science, Bengaluru where she studied muscle development and muscle diseases. After her Ph.D., she worked at the Indian Institute of Science, Education, and Research, Pune as a post-doctoral fellow. She then acquired and executed an independent grant from the DBT-Wellcome Trust India Alliance as an Early Career Fellow. Her work focused on RNA binding proteins and Hedgehog signaling.

See more

She has excellent communication skills and knowledge of scientific publishing with experience in writing scientific documents and grants. She has presented her work in several national and international conferences. With more than 12 years of experience in academia, she has developed strong scientific expertise and teaching skills.

She has always been a curious individual. This led her to pursue a Ph.D. in developmental biology. Apart from the pursuit of knowledge, she takes pleasure in communicating it to a wide range of audiences. She is also a prolific writer. This led her to the path of a medical writer. In this role, she enjoys employing her passion for writing along with her scientific expertise to communicate science.

Besides medical writing, she relishes writing poems, short stories, and plays.

See less

Articles from Shital

Reanalysis of the efficacy of COVID-19 vaccines

Reanalysis of the efficacy of COVID-19 vaccines

Omicron sequences containing Delta mutation detected during SARS-CoV-2 genomic surveillance

Omicron sequences containing Delta mutation detected during SARS-CoV-2 genomic surveillance

Many COVID-19 patients still contagious after five days

Many COVID-19 patients still contagious after five days

Assessing an intranasal lentiviral booster against COVID-19 variants

Assessing an intranasal lentiviral booster against COVID-19 variants

High levels of neutralizing antibodies against Omicron after BNT162b2 booster vaccination

High levels of neutralizing antibodies against Omicron after BNT162b2 booster vaccination

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

Urinary proteomic COV50 marker accurately predicts adverse COVID-19 outcomes

Urinary proteomic COV50 marker accurately predicts adverse COVID-19 outcomes

Test-negative case-control analysis during a Delta variant-dominant period in California’s prisons

Test-negative case-control analysis during a Delta variant-dominant period in California’s prisons

Effectiveness of inactivating SARS-CoV-2 by spraying disinfectant in the form of Dry Fog

Effectiveness of inactivating SARS-CoV-2 by spraying disinfectant in the form of Dry Fog

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.